The store will not work correctly when cookies are disabled.
2-Amino-4-(3-bromo-4-methoxyphenyl)-4H-naphtho(1,2-b)pyran-3-carbonitrile
ID: ALA5203497
Chembl Id: CHEMBL5203497
PubChem CID: 2844733
Max Phase: Preclinical
Molecular Formula: C21H15BrN2O2
Molecular Weight: 407.27
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1Br
Standard InChI: InChI=1S/C21H15BrN2O2/c1-25-18-9-7-13(10-17(18)22)19-15-8-6-12-4-2-3-5-14(12)20(15)26-21(24)16(19)11-23/h2-10,19H,24H2,1H3
Standard InChI Key: OXCYLZAOKAPGPF-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 407.27 | Molecular Weight (Monoisotopic): 406.0317 | AlogP: 4.83 | #Rotatable Bonds: 2 |
Polar Surface Area: 68.27 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.68 | CX LogP: 4.63 | CX LogD: 4.63 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.66 | Np Likeness Score: -0.82 |
References
1. Köhler LHF, Reich S, Yusenko M, Klempnauer KH, Shaikh AH, Ahmed K, Begemann G, Schobert R, Biersack B.. (2022) A New Naphthopyran Derivative Combines c-Myb Inhibition, Microtubule-Targeting Effects, and Antiangiogenic Properties., 13 (11.0): [PMID:36385941] [10.1021/acsmedchemlett.2c00403] |